Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Bosch-Amate

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|September 27, 2021
Anti-Desmocollin Autoantibodies in Autoimmune Blistering DiseasesXavier Bosch-Amate, Pilar Iranzo, Marta Ivars, et al.
Acta Dermato-Venereologica|December 19, 2023
Sweet Syndrome: Clinical Presentation, Malignancy Association, Autoinflammatory Disorders and Treatment Response in a Cohort of 93 Patients with Long-term Follow-upJavier Gil-Lianes, Mar Luque-Luna, Francesc Alamon-Reig, et al.
Acta Dermato-Venereologica|March 9, 2021
Clinicopathological, Genetic and Survival Advantages of Naevus-associated Melanomas: A Cohort StudyXavier Bosch-Amate, Sebastian Podlipnik, Constanza Riquelme-Mc Loughlin, et al.
Clinical and Experimental Dermatology|February 10, 2023
High-risk mucosal human papillomavirus-associated squamous cell carcinoma of the fingers presents distinctive clinicopathological characteristics and outcomes: a bicentric retrospective studyIgnasi Marti-Marti, Xavier Bosch-Amate, Daniel Morgado-Carrasco, et al.
Frontiers in Immunology|June 19, 2023
Case Report: Localized bullous pemphigoid induced by local triggers: a case series and a proposal for diagnostic criteria based on a literature reviewLluís Corbella-Bagot, Javier Gil-Lianes, Javier Fernández-Vela, et al.
Journal of the American Academy of Dermatology|June 5, 2019
Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional studyConstanza Riquelme-Mc Loughlin, Sebastian Podlipnik, Xavier Bosch-Amate, et al.
Allergologia Et Immunopathologia|February 2, 2021
Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approachesNatalia Egri, Ana Esteve-Solé, Àngela Deyà-Martínez, et al.
Acta Dermato-Venereologica|May 21, 2026
Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case SeriesCecilia Tejero-García, Francesc Alamon Reig, Xavier Bosch-Amate, et al.
Seminars in Arthritis and Rheumatism|January 4, 2025
Rheumatologic complications of CAR-T Cell therapy. Experience of a single centerJosé A Gómez-Puerta, Ana Monegal, Andrés Ponce, et al.
Clinical and Experimental Dermatology|March 2, 2024
Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real-world experienceÁlvaro Aguado Vázquez, Andrea Estébanez Corrales, F Javier Melgosa Ramos, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|September 27, 2021
Anti-Desmocollin Autoantibodies in Autoimmune Blistering DiseasesXavier Bosch-Amate, Pilar Iranzo, Marta Ivars, et al.
Acta Dermato-Venereologica|December 19, 2023
Sweet Syndrome: Clinical Presentation, Malignancy Association, Autoinflammatory Disorders and Treatment Response in a Cohort of 93 Patients with Long-term Follow-upJavier Gil-Lianes, Mar Luque-Luna, Francesc Alamon-Reig, et al.
Acta Dermato-Venereologica|March 9, 2021
Clinicopathological, Genetic and Survival Advantages of Naevus-associated Melanomas: A Cohort StudyXavier Bosch-Amate, Sebastian Podlipnik, Constanza Riquelme-Mc Loughlin, et al.
Clinical and Experimental Dermatology|February 10, 2023
High-risk mucosal human papillomavirus-associated squamous cell carcinoma of the fingers presents distinctive clinicopathological characteristics and outcomes: a bicentric retrospective studyIgnasi Marti-Marti, Xavier Bosch-Amate, Daniel Morgado-Carrasco, et al.
Frontiers in Immunology|June 19, 2023
Case Report: Localized bullous pemphigoid induced by local triggers: a case series and a proposal for diagnostic criteria based on a literature reviewLluís Corbella-Bagot, Javier Gil-Lianes, Javier Fernández-Vela, et al.
Journal of the American Academy of Dermatology|June 5, 2019
Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional studyConstanza Riquelme-Mc Loughlin, Sebastian Podlipnik, Xavier Bosch-Amate, et al.
Allergologia Et Immunopathologia|February 2, 2021
Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approachesNatalia Egri, Ana Esteve-Solé, Àngela Deyà-Martínez, et al.
Acta Dermato-Venereologica|May 21, 2026
Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case SeriesCecilia Tejero-García, Francesc Alamon Reig, Xavier Bosch-Amate, et al.
Seminars in Arthritis and Rheumatism|January 4, 2025
Rheumatologic complications of CAR-T Cell therapy. Experience of a single centerJosé A Gómez-Puerta, Ana Monegal, Andrés Ponce, et al.
Clinical and Experimental Dermatology|March 2, 2024
Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real-world experienceÁlvaro Aguado Vázquez, Andrea Estébanez Corrales, F Javier Melgosa Ramos, et al.
Pageof 2